High-quality pancreatic islets are essential for better posttransplantation endocrine function in total pancreatectomy with islet autotransplantation (TPIAT), yet stress during the isolation process affects quality and yield. We analyzed islet-enriched microRNAs (miRNAs) -375 and -200c released during isolation to assess damage and correlated the data with posttransplantation endocrine function. The absolute concentration of miR-375, miR-200c, and C-peptide was measured in various islet isolation steps, including digestion, dilution, recombination, purification, and bagging, in 12 cases of TPIAT. Posttransplantation glycemic control was monitored through C-peptide, hemoglobin A 1c , insulin requirement, and SUITO index. The amount of miR-375 released was significantly higher during enzymatic digestion followed by the islet bagging (P < .001). Mir-200c mirrored these changes, albeit at lower concentrations. In contrast, the C-peptide amount was significantly higher in the purification and bagging steps (P < .001). Lower amounts of miR-375 were associated with a lower 6-month insulin requirement (P = .01) and lower hemoglobin A 1c (P = .04). Measurement of the absolute quantity of miRNA-375 and -200c released during islet isolation is a useful tool to assess islet damage. The quantity of released miRNA is indicative of posttransplantation endocrine function in TPIAT patients.
| INTRODUCTION
Total pancreatectomy with islet autotransplantation (TPIAT) is a promising treatment for patients with chronic pancreatitis who have intractable pain and are resistant to other minimally invasive treatments. 1, 2 In TPIAT, the pancreas is completely resected and the purified islets are infused back into the patient through the portal vein, in order to lessen the risk of postsurgical diabetes mellitus and severe hypoglycemic episodes. [3] [4] [5] In most TPIAT cases, the pancreas is inflamed, fibrotic, and structurally abnormal and islet isolation is challenging. 6, 7 Islets are isolated from human pancreases through use of the semiautomated Ricordi method, 8, 9 a combination of both enzymatic and mechanical digestion of the entire pancreatic tissue to yield considerably pure islets suitable for transplantation. Despite recent advances in islet isolation, such as improvements in the collagenase enzyme blend used for pancreatic digestion and iodixanol-based gradient centrifugation, the islets are still subjected to stress throughout the isolation steps that accounts for considerable variation in islet quality and yield. [10] [11] [12] [13] The transplanted islet dose and the function of islets significantly influence the posttransplantation outcome in clinical islet transplantation.
Development of a sensitive and specific method to measure damage to the islets based on biomarkers during the isolation procedure could lead to strategies to improve islet viability and potency.
Abbreviations: ANOVA, analysis of variance; AUC, area under the curve; IEQ, islet equivalents; LNA, locked nucleic acid; miR, microRNA; qPCR, quantitative polymerase chain reaction; TPIAT, total pancreatectomy with islet autotransplantation.
Traditional islet-specific biomarkers, such as C-peptide, proinsulin, GAD-65, and insulin, are not suitable for accurate assessment of islet damage during the clinical islet isolation procedure because they are released or induced by the components of the media used in the isolation process, like glucose or serum. Previously, we demonstrated that microRNA (miRNA [miR] )-375 is a highly sensitive and reliable marker for acute islet cell damage in islet transplant patient plasma samples. 14 Furthermore, recently, we reported that miR-375 and miR-200c are biomarkers that predict posttransplantation graft function in patients with TPIAT. 15 In the current study, we measured the absolute amount of miR-375, miR-200c, and C-peptide released during multiple stages of the islet isolation process, such as organ transportation, enzyme perfusion, pancreas digestion, islet purification, tissue recombination, and islet bagging, in 12 TPIAT cases. The quantified miRNA information was then correlated with the corresponding TPIAT recipient's posttransplantation endocrine graft function parameters-C-peptide level, SUITO index, glycated hemoglobin, and exogenous insulin requirement-for validation of the biomarkers as a way to monitor islet damage during clinical islet isolations.
| MATERIALS AND METHODS

| Islet isolation
This study included 12 patients who underwent TPIAT after 2015 at our center (institutional review board No. 010-150). Immediately after the total pancreatectomy, the pancreas was transported to the islet isolation facility in cold storage/purification stock solution (Mediatech, Manassas, VA). Details of the islet isolation method have been described previously. 16, 17 Briefly, the pancreatic duct was cannulated, followed by ductal preservation with perfusion solution. The pancreas was perfused with collagenase enzyme blended with either neutral protease or thermolysin (Serva Electrophoresis GMbH, Heidelberg, Germany, or Roche Molecular Diagnostics, Indianapolis, IN). The pancreas was digested by using a modified Ricordi method. 16 Islets were purified with continuous iodixanol-based density gradient centrifugation byusing the COBE 2991 cell processor (CaridianBCT, Inc., Lakewood, CO) when the packed tissue volume of the digest exceeded 25% of the recipient's body weight. Islet purity and quantity were evaluated with dithizone staining (Sigma Chemical Co., St. Louis, MO).
The total islet counts were measured before and after purification and were represented as islet equivalents (IEQ) based on a size of 150 μm.
Final islet products were suspended in the transplant medium (CMRL 1066; Corning, Corning, NY) and then placed in infusion bag(s). These freshly bagged islets were infused intraportally with heparin at a dose of 70 U/kg patient weight under general anesthesia induced for total pancreatectomy.
| Sample collection
Aliquots of media samples (2 mL) were collected at various stages of the isolation process as described in Ricordi et al. 16 The stages included organ transportation; enzyme perfusion; digestion of the pancreas at minutes 10, 20, and 30; end of the digestion; recombination of pancreas tissue after digestion; purification of recombined digested pancreas tissue; and bagging of the purified islets. Samples during the digestion step were collected from the circuit port located at the recirculation-dilution switch using a 3-mL syringe. This port is used for collecting samples at regular intervals for assess- 
| Patient follow-up
After transplantation, patients' islet graft function was monitored based on metabolic assessments. Data were obtained for the following parameters: fasting C-peptide, fasting blood glucose, hemoglobin 
| Statistical analysis
The miR-375 and miR-200c quantification data were analyzed by 2-way analysis of variance (ANOVA) followed by the Tukey multiple comparison test to find the significance. The C-peptide data were analyzed by 1-way ANOVA followed by the Dunnett multiple comparison test to find the significance. The Pearson 2-tailed correlation analysis was performed to find the correlation between miR-375 area under the curve (AUC) D and isolation characteristics as well as 6-month posttransplantation endocrine function. Unpaired t test was performed to find the significance between the low and high miR-375 release groups with respect to 6-month posttransplantation islet graft function. All statistical analyses were carried out by using GraphPad Prism6 (Graphpad Software, Inc., San Diego, CA).
| RESULTS
| Quantification of miR-375, miR-200c, and C-peptide during islet isolation
Twelve TPIAT cases were included in this study. The characteristics of patients and islets are described in Table 1 . The cohort of patients included in this study is representative of patients described in previous released during the pancreas digestion at 10 and 20 minutes was significantly higher than that released during transport (P < .001). In contrast, the C-peptide amount was significantly higher in the purification and bagging samples compared with the transport sample (P < .001).
The Figure 3A ), 3 months (r = 0.04, P = .9, n = 11, Figure 3B ), or 6 months (r = 0.46, P = .20, n = 9, Figure 3C ). Similarly, miR-375 (AUC) D was not significantly correlated with SUITO index (1 month: r = 0.36, P = .27, n = 11, Figure 3D ; 3 months: r = −0.07, P = .83, n = 11, Figure 3E ; 6 months: r = −0.48, P = .18, n = 9, Figure 3F ). Results from 1-month or 3-month hemoglobin A 1c (1 month: r = −0.13, P = .72, n = 9, Figure 3G; 3 months: r = 0.27, P = .44, n = 10, Figure 3H ) and exogenous insulin significance of differences between the low and high release groups.
| Correlation of miR-375 released during digestion with islet yield
TPIAT patients from the low release group required significantly less exogenous insulin (P = .010; n = 4 for high; n = 6 for low) and showed low levels of hemoglobin A 1c (P = .038; n = 3 for high; n = 6 for low) compared with the high miR-375 release group. Moreover, the low miR-375 release group showed no significance with C-peptide (P = .150; n = 3 for high; n = 6 for low) and SUITO index (P = .160; n = 3 for high; n = 6 for low) at 6 months posttransplantation compared with the high miR-375 release group. The correlation analysis of high group that released more miR-375 during digestion per gram pancreas processed also showed poor transplantation outcome at 6 months (data not shown).
| DISCUSSION
The main objective of the study was to identify the isolation step at which the islets undergo major damage using miR-375 and miR-200c as biomarkers. Minimizing damage during isolation will increase viable islet mass isolated for transplantation. Among TPIAT recipients, a higher mass of transplanted islets has been shown to be critical for better endocrine function in the posttransplantation period. 1 Here,
we analyzed clinical islet isolations from 12 patients with chronic pancreatitis. We categorized the islet isolation process into 9 major steps, beginning with the transportation of the pancreas and ending with the bagging of islets for intraportal infusion. Based on the consistent Recently, unmethylated insulin DNA has been shown to be suitable for the assessment of islet damage in TPIAT patients. 28 The ratio of unmethylated total insulin DNA increased after islet infusion from 0.13 to 0.7 and peaked in the first few hours. This peak represented a weak elevation compared with the fold increase in miR-375, which ranged from 1 to 1500 during the same period in 
P=0
.038* our study. 14 Unlike miR-375, no correlation was established between the methylated DNA released and posttransplantation glycemic control.
The quantity of miR-375 released during the digestion step correlated with the total islet yield in the TPIAT cases, indicating its specificity for islets and further corroborating our previous report. 14 In the present study, we observed that TPIAT patients who had lower miR-375 release (<0.4 fmol/IEQ) during the digestion had significantly better glycemic control based on lower insulin requirement and hemoglobin A 1c compared to TPIAT patients with a higher miR-375 release (>0.4 fmol/IEQ). Other measurements of glycemic control such as fasting C-peptide and SUITO index also mirrored these results but without reaching statistical significance.
In summary, the results of the present study suggest that measurement of the absolute quantity of miR-375 and miR-200c released during digestion is a reliable noninvasive method not only to monitor islet damage during clinical islet isolation but also to predict the endocrine function of the transplanted autologous islets. In majority of the cases studied, the peak miR release was observed at 10 minutes of digestion and, hence, measurement of miR can be used to assess islet damage. One of the limitations of this study is that the data presented were collected from TPIAT cases performed at 1 center. Additional studies involving multiple centers will provide independent validation of the results presented in this manuscript. Furthermore, novel collagenase blends can be tested for their ability to cause less damage to islets during the digestion process.
The enzymes used for pancreas digestion are critical; however, the concentration of the enzyme mixture required for optimal digestion remains to be standardized. Each batch of collagen enzyme is composed of different formulations of recombinant class I and class II collagenases, and the concentration of neutral proteases required for digestion also varies. 29 The enzyme dose has to be adjusted for the condition of the pancreas, such as age, extent of fibrosis, calcification, and texture. This study offers a reliable method to assess the damage to islets exerted due to changes in digestion conditions. Results from multiple donor organs and multiple centers can be pooled to define ideal conditions for isolating functional islets from different types of donor pancreases. The results of this study should also be validated with deceased donor pancreatic islet isolations for allogeneic islet transplantation.
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